Diurnal Group PLC Director/PDMR Shareholding (9212H)
05 August 2019 - 9:27PM
UK Regulatory
TIDMDNL
RNS Number : 9212H
Diurnal Group PLC
05 August 2019
5 August 2019
Diurnal Group plc
("Diurnal" or the "Company")
Grant of Deferred Share Awards
Director and PDMR Dealings
Diurnal Group plc (AIM: DNL), the specialty pharmaceutical
company targeting patient needs in chronic endocrine (hormonal)
diseases, announces the following deferred bonus share awards over
ordinary shares of 5 pence ("Ordinary Shares") in Diurnal were
granted under the Diurnal Group plc Long Term Incentive Plan (the
"Plan") to persons discharging managerial responsibilities ("PDMR")
in respect of the bonus due for the financial year ended 30 June
2019:
PDMR Total number of shares under award Type of award
Martin Whitaker 143,443 Deferred bonus share
----------------------------------- ---------------------
Richard Bungay 86,066 Deferred bonus share
----------------------------------- ---------------------
Richard Ross 30,256 Deferred bonus share
----------------------------------- ---------------------
Under the rules of the Plan, up to 50% of the annual bonus
payable to the senior management team are settled in deferred share
bonus awards. Annual bonuses are payable at the sole discretion of
the Remuneration Committee on the basis set out in the 2018 annual
report. The bonus performance criteria for 2018/2019 included
clinical and commercial milestones. The deferred bonus share awards
will ordinarily vest on the first anniversary of their grant,
subject to the grantee's continued service. The awards were granted
under award agreements that incorporated the terms of the Plan. No
consideration is due to be payable on vesting.
This notification is made in accordance with the Market Abuse
Regulation.
For further information, please visit www.diurnal.co.uk or contact:
+44 (0)20 3727
Diurnal Group plc 1000
Martin Whitaker, Chief Executive Officer
Richard Bungay, Chief Financial Officer
Panmure Gordon (UK) Limited (Nominated Adviser +44 (0) 20 7886
and Joint Broker) 2500
Corporate Finance: Freddy Crossley, Emma Earl
Corporate Broking: James Stearns
+44 (0) 20 7894
Cantor Fitzgerald Europe (Joint Broker) 7000
Corporate Finance: Phil Davies, Will Goode,
Michael Boot
Healthcare Equity Sales: Andrew Keith
+44 (0)20 3727
FTI Consulting 1000
Simon Conway
Victoria Foster Mitchell
Notes to Editors
About Diurnal Group plc
Founded in 2004, Diurnal is a UK-based specialty pharma company
developing high quality products for the global market for the
life-long treatment of chronic endocrine conditions, including
Congenital Adrenal Hyperplasia and Adrenal Insufficiency. Its
expertise and innovative research activities focus on
circadian-based endocrinology to yield novel product candidates in
the rare and chronic endocrine disease arena.
For further information about Diurnal, please visit
www.diurnal.co.uk
Notification and public disclosure of transactions by persons
discharging managerial responsibilities and persons closely
associated with them
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Martin Whitaker
------------------------------------- --------------------------------------------------
2 Reason for the notification
-----------------------------------------------------------------------------------------
a) Position/status Chief Executive Officer
------------------------------------- --------------------------------------------------
b) Initial notification Initial notification
/Amendment
------------------------------------- --------------------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
-----------------------------------------------------------------------------------------
a) Name Diurnal Group plc
------------------------------------- --------------------------------------------------
b) LEI 213800I2HNUNZN1LDH29
------------------------------------- --------------------------------------------------
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
-----------------------------------------------------------------------------------------
a) Description of the Ordinary Shares of 5 pence each in Diurnal
financial instrument, Group plc
type of instrument
Identification code GB00BDB6Q760
b) Nature of the transaction Grant of nil cost awards under the Diurnal
Group plc Long Term Incentive Plan as
follows:
Deferred bonus award over 143,443 ordinary
shares.
The deferred bonus award will ordinarily
vest on the first anniversary of their
grant subject to continued service.
------------------------------------- --------------------------------------------------
c) Price(s) and volume(s)
----------------------- ----------------------
Price(s) Volume(s)
----------------------- ----------------------
GBPnil 143,443
------------------------------------------------------------------ ----------------------
d) Aggregated information
- Aggregated volume 143,443
- Price GBPnil
e) Date of the transaction 5 August 2019
------------------------------------- --------------------------------------------------
f) Place of the transaction Outside a trading venue
------------------------------------- --------------------------------------------------
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Richard Bungay
------------------------------------- -------------------------------------------------
2 Reason for the notification
----------------------------------------------------------------------------------------
a) Position/status Chief Financial Officer
------------------------------------- -------------------------------------------------
b) Initial notification Initial notification
/Amendment
------------------------------------- -------------------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
----------------------------------------------------------------------------------------
a) Name Diurnal Group plc
------------------------------------- -------------------------------------------------
b) LEI 213800I2HNUNZN1LDH29
------------------------------------- -------------------------------------------------
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
----------------------------------------------------------------------------------------
a) Description of the Ordinary Shares of 5 pence each in Diurnal
financial instrument, Group plc
type of instrument
Identification code GB00BDB6Q760
b) Nature of the transaction Grant of nil cost awards under the Diurnal
Group plc Long Term Incentive Plan as
par value options as follows:
Deferred bonus award over 86,066 ordinary
shares.
The deferred bonus award will ordinarily
vest on the first anniversary of their
grant subject to continued service.
------------------------------------- -------------------------------------------------
c) Price(s) and volume(s)
----------------------- ---------------------
Price(s) Volume(s)
----------------------- ---------------------
GBPnil 86,066
------------------------------------------------------------------ ---------------------
d) Aggregated information
- Aggregated volume 86,066
- Price GBPnil
e) Date of the transaction 5 August 2019
------------------------------------- -------------------------------------------------
f) Place of the transaction Outside a trading venue
------------------------------------- -------------------------------------------------
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Richard Ross
------------------------------------- -------------------------------------------------
2 Reason for the notification
----------------------------------------------------------------------------------------
a) Position/status Chief Scientific Officer
------------------------------------- -------------------------------------------------
b) Initial notification Initial notification
/Amendment
------------------------------------- -------------------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
----------------------------------------------------------------------------------------
a) Name Diurnal Group plc
------------------------------------- -------------------------------------------------
b) LEI 213800I2HNUNZN1LDH29
------------------------------------- -------------------------------------------------
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
----------------------------------------------------------------------------------------
a) Description of the Ordinary Shares of 5 pence each in Diurnal
financial instrument, Group plc
type of instrument
Identification code GB00BDB6Q760
b) Nature of the transaction Grant of nil cost awards under the Diurnal
Group plc Long Term Incentive Plan as
par value options as follows:
Deferred bonus award over 30,256 ordinary
shares.
The deferred bonus award will ordinarily
vest on the first anniversary of their
grant subject to continued service.
------------------------------------- -------------------------------------------------
c) Price(s) and volume(s)
----------------------- ---------------------
Price(s) Volume(s)
----------------------- ---------------------
GBPnil 30,256
------------------------------------------------------------------ ---------------------
d) Aggregated information
- Aggregated volume 30,256
- Price GBPnil
e) Date of the transaction 5 August 2019
------------------------------------- -------------------------------------------------
f) Place of the transaction Outside a trading venue
------------------------------------- -------------------------------------------------
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
DSHSSDFFIFUSEEA
(END) Dow Jones Newswires
August 05, 2019 07:27 ET (11:27 GMT)
Diurnal (LSE:DNL)
Historical Stock Chart
From Apr 2024 to May 2024
Diurnal (LSE:DNL)
Historical Stock Chart
From May 2023 to May 2024